Explore the vast range of titles available.

The most aggressive form of brain tumor is gliomas, which leads to concise life when high grade. The early detection of glioma is important to save the life of patients. MRI is a commonly used approach for brain tumors evaluation. However, the massive amount of data provided by MRI prevents manual segmentation in a reasonable time, restricting the use of accurate quantitative measurements in clinical practice. An automatic and reliable method is required that can segment tumors accurately. To achieve end-to-end brain tumor segmentation, a hybrid deep learning model RMU-Net is proposed. The architecture of MobileNetV2 is modified by adding residual blocks to learn in-depth features. This modified Mobile Net V2 is used as an encoder in the proposed network, and upsampling layers of U-Net are used as the decoder part. The proposed model has been validated on BraTS 2020, BraTS 2019, and BraTS 2018 datasets. The RMU-Net achieved the dice coefficient scores for WT, TC, and ET of 91.35%, 88.13%, and 83.26% on the BraTS 2020 dataset, 91.76%, 91.23%, and 83.19% on the BraTS 2019 dataset, and 90.80%, 86.75%, and 79.36% on the BraTS 2018 dataset, respectively. The performance of the proposed method outperforms with less computational cost and time as compared to previous methods.

Brain tumor segmentation seeks to separate healthy tissue from tumorous regions. This is an essential step in diagnosis and treatment planning to maximize the likelihood of successful treatment. Magnetic resonance imaging (MRI) provides detailed information about brain tumor anatomy, making it an important tool for effective diagnosis which is requisite to replace the existing manual detection system where patients rely on the skills and expertise of a human. In order to solve this problem, a brain tumor segmentation & detection system is proposed where experiments are tested on the collected BraTS 2018 dataset. This dataset contains four different MRI modalities for each patient as T1, T2, T1Gd, and FLAIR, and as an outcome, a segmented image and ground truth of tumor segmentation, i.e., class label, is provided. A fully automatic methodology to handle the task of segmentation of gliomas in pre-operative MRI scans is developed using a U-Net-based deep learning model. The first step is to transform input image data, which is further processed through various techniques—subset division, narrow object region, category brain slicing, watershed algorithm, and feature scaling was done. All these steps are implied before entering data into the U-Net Deep learning model. The U-Net Deep learning model is used to perform pixel label segmentation on the segment tumor region. The algorithm reached high-performance accuracy on the BraTS 2018 training, validation, as well as testing dataset. The proposed model achieved a dice coefficient of 0.9815, 0.9844, 0.9804, and 0.9954 on the testing dataset for sets HGG-1, HGG-2, HGG-3, and LGG-1, respectively.

Prediction of overall survival based on multimodal MRI of brain tumor patients is a difficult problem. Although survival also depends on factors that cannot be assessed via preoperative MRI such as surgical outcome, encouraging results for MRI-based survival analysis have been published for different datasets. We assess if and how established radiomic approaches as well as novel methods can predict overall survival of brain tumor patients on the BraTS challenge dataset. This dataset consists of multimodal preoperative images of 211 glioblastoma patients from several institutions with reported resection status and known survival. In the official challenge setting, only patients with a reported gross total resection are taken into account. We therefore evaluated previously published methods as well as different machine learning approaches on the BraTS dataset. For different types of resection status, these approaches are compared to a baseline, a linear regression on patient age only. This naive approach won the 3rd place out of 26 participants in the BraTS survival prediction challenge 2018. Previously published radiomic signatures show significant correlations and predictiveness to patient survival for patients with a reported subtotal resection. However, for patients with reported gross total resection, none of the evaluated approaches was able to outperform the age-only baseline in a cross-validation setting, explaining the poor performance of approaches based on radiomics in the BraTS challenge 2018.